Kinase Inhibitors of DNA-PK, ATM and ATR in Combination with Ionizing Radiation Can Increase Tumor Cell Death in HNSCC Cells While Sparing Normal Tissue Cells

Jost T, Faulhaber EM, Symank JA, Scheper J, Bürkel F, Fietkau R, Hecht M, Distel L (2022)

Publication Type: Conference contribution, Abstract of a poster

Publication year: 2022

Journal

Oncology Research and Treatment Karger Publishers

Publisher: KARGER

City/Town: BASEL

Pages Range: 132-132

Conference Proceedings Title: ONCOLOGY RESEARCH AND TREATMENT

DOI: 10.3390/genes12060925

Authors with CRIS profile

Tina Jost Department of Radiation Oncology Eva-Maria Faulhaber Medizinische Fakultät Julia-Alice Symank Medizinische Fakultät Felix Bürkel Medizinische Fakultät Rainer Fietkau Lehrstuhl für Strahlentherapie Markus Hecht Department of Radiation Oncology Luitpold Distel Department of Radiation Oncology

How to cite

APA:

Jost, T., Faulhaber, E.-M., Symank, J.-A., Scheper, J., Bürkel, F., Fietkau, R.,... Distel, L. (2022, November). Kinase Inhibitors of DNA-PK, ATM and ATR in Combination with Ionizing Radiation Can Increase Tumor Cell Death in HNSCC Cells While Sparing Normal Tissue Cells. Poster presentation.

MLA:

Jost, Tina, et al. "Kinase Inhibitors of DNA-PK, ATM and ATR in Combination with Ionizing Radiation Can Increase Tumor Cell Death in HNSCC Cells While Sparing Normal Tissue Cells." Presented at ONCOLOGY RESEARCH AND TREATMENT BASEL: KARGER, 2022.

BibTeX: Download